A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

NCT05691712 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Disease
Endocrine System Diseases

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

Eli Lilly and Company